Max-Planck spin-off company performing target deconvolution by forward genetics. Unbiased identification of target structures at unmatched amino acid resolution mapping compound-target binding interfaces. Importantly our technology interrogates the entire genome including essential genes. Further applications of our platform technology include off-target identification and resistance prediction.